Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Jun 3, 2026

Clonogenic Assay: Adherent Cells

Clonogenic Assay: Adherent Cells

Published on: March 13, 2011

Cell sensitivity assays : clonogenic assay.

¹CRC Department of Medical Oncology, Beatson Laboratories, University of Glasgow, Glasgow, UK.

Methods in Molecular Medicine

|March 5, 2011

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Evaluating the potential of polymer nanoparticles for oral delivery of paclitaxel in drug-resistant cancer.

Cancer nanotechnology·2015

Same author

Candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer identified by methylome and expression profiling.

Oncogene·2012

Same author

Cell sensitivity assays : the MTT assay.

Methods in molecular medicine·2011

Same author

Pharmacokinetic and pharmacodynamic properties of an oral formulation of the histone deacetylase inhibitor Belinostat (PXD101).

Cancer chemotherapy and pharmacology·2010

Same author

Combined inhibition of DNA methylation and histone acetylation enhances gene re-expression and drug sensitivity in vivo.

British journal of cancer·2009

Same author

CpG-island methylation and epigenetic control of resistance to chemotherapy.

Biochemical Society transactions·2004

Same journal

Erratum to: Immunotherapeutic Approach to Cancer with Cutaneous DNA Vaccination.

Methods in molecular medicine·2015

Same journal

Methods for cancer gene therapy using tumor suppressor genes.

Methods in molecular medicine·2014

Same journal

Suppression of the human carcinoma phenotype by an antioncogene ribozyme.

Methods in molecular medicine·2014

Same journal

Methods for the use of stromal cells for therapeutic gene therapy.

Methods in molecular medicine·2014

Same journal

Methods for adenovirus-mediated gene transfer to synovium in vivo.

Methods in molecular medicine·2014

Same journal

Methods for gene transfer to synovium.

Methods in molecular medicine·2014

See all related articles

Cell culture assays evaluate anticancer drug toxicity by measuring either cell survival or cytotoxicity. Both methods assess drug effects, with survival assays focusing on proliferation potential after treatment.

Area of Science:

Pharmacology
Cell Biology
Toxicology

Background:

Cell culture systems have been used for over 50 years to assess anticancer agent toxicity.
Anticancer drug efficacy is evaluated using various assays measuring cellular drug sensitivity.
Assays for drug toxicity fall into two main categories: cell survival and cytotoxicity.

Purpose of the Study:

To review and differentiate between cell survival and cytotoxicity assays.
To highlight the methodologies and applications of these assays in drug development.

Main Methods:

Cytotoxicity assays (e.g., trypan blue dye exclusion, 51Cr release, 3H-thymidine incorporation) assess cellular structural integrity and metabolic function post-drug exposure.
Cell survival assays measure the ultimate outcome of drug effects, focusing on cell death or recovery.

More Related Videos

Screening Ion Channels in Cancer Cells

Screening Ion Channels in Cancer Cells

Published on: June 16, 2023

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Published on: May 23, 2025

Related Experiment Videos

Last Updated: Jun 3, 2026

Clonogenic Assay: Adherent Cells

Clonogenic Assay: Adherent Cells

Published on: March 13, 2011

Screening Ion Channels in Cancer Cells

Screening Ion Channels in Cancer Cells

Published on: June 16, 2023

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Published on: May 23, 2025

Cell survival assays often estimate the colony-forming ability of individual cells.

Main Results:

Cytotoxicity assays provide insights into immediate cellular damage and function.
Cell survival assays quantify the long-term proliferative capacity of cells after treatment.
A recovery period in cytotoxicity assays can allow for proliferation assessment, similar to clonogenic assays.

Conclusions:

Understanding the distinction between cell survival and cytotoxicity assays is crucial for accurate drug toxicity assessment.
Both assay types offer valuable, albeit different, information regarding anticancer agent effects on cells.
Methodologies exist to bridge the gap between cytotoxicity and cell survival measurements.